PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
37.12%
Some net income increase while ADI is negative at -26.77%. John Neff would see a short-term edge over the struggling competitor.
-1.26%
Negative yoy D&A while ADI is 0.99%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
120.83%
Some yoy growth while ADI is negative at -69.15%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
17.19%
SBC growth while ADI is negative at -8.52%. John Neff would see competitor possibly controlling share issuance more tightly.
-153.88%
Both reduce yoy usage, with ADI at -88.53%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-129.40%
Both yoy AR lines negative, with ADI at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-37.36%
Negative yoy inventory while ADI is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-209.91%
Negative yoy AP while ADI is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-292.59%
Negative yoy usage while ADI is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
99.15%
Some yoy increase while ADI is negative at -79.17%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-66.82%
Both yoy CFO lines are negative, with ADI at -33.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
12.50%
Lower CapEx growth vs. ADI's 51.30%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
18.91%
Purchases well above ADI's 12.15%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
9.86%
Proceeds from sales/maturities above 1.5x ADI's 1.13%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
111.64%
Lower net investing outflow yoy vs. ADI's 250.67%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
241.35%
Issuance growth of 241.35% while ADI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-13.17%
We cut yoy buybacks while ADI is 18.24%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.